Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA expedites Aspen's prostate drug ahead of merger
FDA expedites Aspen's prostate drug ahead of merger
FDA expedites Aspen's prostate drug ahead of merger
Submitted by
admin
on August 18, 2016 - 4:52pm
Source:
BioPharma Dive
News Tags:
FDA
Aspen Park Pharmaceuticals
Tamsulosin DRS
M&A
benign prostatic hyperplasia
Headline:
FDA expedites Aspen's prostate drug ahead of merger
Do Not Allow Advertisers to Use My Personal information
